skip to main content

Amyloid-beta clearance in Alzheimer's disease

2015

Online access

  • Title:
    Amyloid-beta clearance in Alzheimer's disease
  • Subjects: Alzheimer's disease; Alzheimer's disease -- Pathogenesis; Alzheimer's disease -- Molecular aspects; Neurosciences; Electronic books
  • Description: Strong evidence continues to accumulate indicating that amyloid-beta (Aβ) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aβ are of great interest in understanding AD pathogenesis and the development of effective treatments. This topic focuses on the issues related to Aβ clearance in AD. The topics covered include proteases that degrade Aβ and their localization, regulation, and functions. This topic also covers issues related to clearance through uptake by glia and through low-density lipoprotein (LDL) receptor mediated mechanisms. Signal transduction related to AD pathology and clearance is also addressed. Finally, immunotherapy and other novel therapeutic approaches are discussed.
  • Publisher: Place of publication not identified : Frontiers Media SA
  • Creation Date: 2015
  • Format: 1 online resource (111 pages) : illustrations; digital, PDF file(s)..
  • Language: English
  • Institution Zone MMS ID: 991003053226803381$$I01TRAILS_CARROLL
    991000611243903376$$I01TRAILS_MSU_GFC
    991009758816103368$$I01TRAILS_MSU
    991003863048603375$$I01TRAILS_MSU_NORTH
    991000541155203380$$I01TRAILS_ROCKY
    9927509731503367$$I01TRAILS_UM
    991002135293803382$$I01TRAILS_UGF
  • Network Zone MMS ID: 9911536730203366
  • Source: 01TRAILS ALMA

Searching Remote Databases, Please Wait